Corona Remedies to Expand Bhayla Manufacturing Capacity by 400 Million Units
Corona Remedies Limited has announced an expansion of manufacturing capacity at its Bhayla formulation facility to support rising demand for its products. The expansion will add 400 million units of tablet and capsule capacity, with 240 million units expected to be available for utilisation.
Corona Remedies | 29/12/2025 | By Darshana | 148
CORONA Remedies to Launch its New Hormonal Products Manufacturing Plant in Ahmedabad
Commercial production is expected to commence in FY 2026, marking a significant step forward in CORONA’s commitment to women’s healthcare.
CORONA Remedies | 29/11/2024 | By Aishwarya | 534
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy